← Back to Search

mTOR Inhibitor

Sirolimus 2Mg Tab for Cancer

Phase 2
Waitlist Available
Led By Sanjay Goel, MD
Research Sponsored by Albert Einstein College of Medicine
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 6 months
Awards & highlights

Study Summary

This trial will test the effectiveness of sirolimus in treating metastatic dMMR solid cancer.

Eligible Conditions
  • Metastatic dMMR Solid Cancer
  • Solid Tumors
  • Cancer
  • Metastatic Tumor

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~6 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and 6 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Overall Response Rate
Secondary outcome measures
Overall Survival (OS) - median months
Progression Free Survival (PFS) - median months
Response Duration (months)

Trial Design

1Treatment groups
Experimental Treatment
Group I: SirolimusExperimental Treatment1 Intervention
Participants will be instructed to take 2 mg every day for 28 days (1 cycle). They will be evaluated in the oncology clinic every 2 weeks to make sure they are tolerating the medication well.

Find a Location

Who is running the clinical trial?

Albert Einstein College of MedicineLead Sponsor
285 Previous Clinical Trials
11,854,636 Total Patients Enrolled
Sanjay Goel, MDPrincipal InvestigatorMontefiore Medical Center
1 Previous Clinical Trials
60 Total Patients Enrolled
Chaoyuan Kuang, MDPrincipal InvestigatorMontefiore Medical Center

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

What indications is Sirolimus 2Mg Tab most often prescribed for?

"Sirolimus 2Mg Tab is a medication that can help patients who have received a liver transplant and are struggling with rejection. Additionally, this drug has potential to improve kidney disease and renal angiomyolipomas."

Answered by AI

How many patients are being enrolled in this trial?

"That is correct. The listing on clinicaltrials.gov suggests that the study team is still recruiting patients for this trial. This particular research project was first posted on June 3rd, 2020 and has been edited as recently as June 3rd, 2022. They are looking for a total of 16 individuals who meet the eligibility criteria across 1 site."

Answered by AI

Are people still being signed up to participate in this drug trial?

"The information on clinicaltrials.gov does show that this study is looking for 16 participants at 1 location and it was originally posted on 6/3/2020 with the most recent edit being on 6/3/2022."

Answered by AI

If I meet the requirements, can I sign up for this clinical trial?

"The 16 patients that will be allowed to participate in this clinical trial must have a malignant tumor and fall in the age range of 18 to 65 years old."

Answered by AI

Are there any other examples in the medical literature of Sirolimus 2Mg Tab being used?

"Currently, there are 130 clinical trials involving Sirolimus 2Mg Tab underway. Of these studies, 13 are in Phase 3. The locations of these trials span 1084 different sites with several being based in Cincinnati, Ohio."

Answered by AI

Does this research require that participants be over 30 years of age?

"In order to be eligible for this specific study, patients must fall within the age range of 18-65. There are 447 trials that test subjects under 18 and 2960 research projects for individuals over 65 years old."

Answered by AI

Are there any negative health effects associated with Sirolimus 2Mg Tab?

"Sirolimus 2Mg Tab received a safety score of 2 because there is some data supporting safety, but no clinical evidence yet demonstrating its efficacy."

Answered by AI
~1 spots leftby Mar 2025